^SAMPLE = GSM287015!Sample_title = 528 - mAdbID:76803!Sample_geo_accession = GSM287015!Sample_status = Public on Sep 04 2008!Sample_submission_date = May 06 2008!Sample_last_update_date = Nov 26 2008!Sample_type = genomic!Sample_channel_count = 2!Sample_source_name_ch1 = Normal Lymphocytes!Sample_organism_ch1 = Homo sapiens!Sample_taxid_ch1 = 9606!Sample_characteristics_ch1 = Tissue: lymphocytes!Sample_molecule_ch1 = genomic DNA!Sample_extract_protocol_ch1 = Sample DNA Extraction Protocol!Sample_extract_protocol_ch1 = Other: The DNA was isolated by Qiagen DNeasy Tissue kit according to the manufacturer's recommendations.!Sample_label_ch1 = cy5!Sample_label_protocol_ch1 = NimbleGen Cy5 Sample Labeling Protocol!Sample_label_protocol_ch1 = Other: Proprietary protocol information available at http://www.nimblegen.com/technology/index.html!Sample_source_name_ch2 = 528!Sample_organism_ch2 = Homo sapiens!Sample_taxid_ch2 = 9606!Sample_characteristics_ch2 = Gender: male!Sample_characteristics_ch2 = Age: 42!Sample_characteristics_ch2 = Tissue: lymph node!Sample_characteristics_ch2 = Disease state: Lymphoma!Sample_characteristics_ch2 = Individual: 528!Sample_characteristics_ch2 = Clinical info: Submitting diagnosis: DLBCL!Sample_characteristics_ch2 = Clinical info: Final microarray diagnosis: Unclassified DLBCL!Sample_characteristics_ch2 = Clinical info: Follow up status: ALIVE!Sample_characteristics_ch2 = Clinical info: Follow up years: 1.64!Sample_characteristics_ch2 = Clinical info: Chemotherapy: CHOP-Like Regimen!Sample_characteristics_ch2 = Clinical info: ECOG performance status: 1!Sample_characteristics_ch2 = Clinical info: Stage: 3!Sample_characteristics_ch2 = Clinical info: LDH ratio: 0.85!Sample_characteristics_ch2 = Clinical info: Number of extranodal sites: 0!Sample_molecule_ch2 = genomic DNA!Sample_extract_protocol_ch2 = Sample DNA Extraction Protocol!Sample_extract_protocol_ch2 = Other: The DNA was isolated by Qiagen DNeasy Tissue kit according to the manufacturer's recommendations.!Sample_label_ch2 = cy3!Sample_label_protocol_ch2 = NimbleGen Cy3 Sample Labeling Protocol!Sample_label_protocol_ch2 = Other: Proprietary protocol information available at http://www.nimblegen.com/technology/index.html!Sample_hyb_protocol = NimbleGen Hybridization Protocol!Sample_hyb_protocol = Other: Proprietary protocol information available at http://www.nimblegen.com/technology/index.html!Sample_scan_protocol = NimbleGen Scanning Protocol!Sample_scan_protocol = Other: Scanning was performed using a GenePix4000B scanner (Axon instruments). NimbleGen proprietary protocol information available at http://www.nimblegen.com/technology/index.html.!Sample_description = mAdb experiment ID: 76803!Sample_data_processing = NimbleGen Data Processing!Sample_data_processing = Calculation Method: Scaled log2-ratio data GFF file (ratio of control vs. sample for individual probes).!Sample_platform_id = GPL6400!Sample_contact_name = Louis,M.,Staudt!Sample_contact_email = lstaudt@mail.nih.gov!Sample_contact_phone = 301-402-1892!Sample_contact_laboratory = Louis M Staudt!Sample_contact_department = Lymphoid Malignancies Branch!Sample_contact_institute = National Cancer Institute!Sample_contact_address = 9000 Rockville Pike, Bldg 10, Rm 4N114!Sample_contact_city = Bethesda!Sample_contact_state = MD!Sample_contact_zip/postal_code = 20892!Sample_contact_country = USA!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM287nnn/GSM287015/suppl/GSM287015.txt.gz!Sample_series_id = GSE11318!Sample_data_row_count = 386165#ID_REF = NCI mAdb well id plus replicate number#VALUE = log ratio (log2 of CY5 channel/CY3 channel)!sample_table_beginID_REF	VALUE5921655_1	-0.4535921656_1	-0.1405921657_1	-0.0325921658_1	0.1915921659_1	0.5265921660_1	0.2015921661_1	0.9685921662_1	0.4735921663_1	0.3285921664_1	0.2845921665_1	0.2845921666_1	-0.2725921667_1	0.0845921668_1	-0.0255921669_1	0.4585921670_1	0.3935921671_1	0.0515921672_1	-0.0875921673_1	0.3445921674_1	0.143!sample_table_end